West Paces Advisors Inc. Boston Scientific Corp Transaction History

West Paces Advisors Inc.

  • $379 Billion
  • Q1 2024

A detailed history of West Paces Advisors Inc. transactions in Boston Scientific Corp stock. As of the latest transaction made, West Paces Advisors Inc. holds 2,347 shares of BSX stock, worth $178,630. This represents 0.04% of its overall portfolio holdings.

Number of Shares
2,347
Previous 2,375 1.18%
Holding current value
$178,630
Previous $137 Million 17.08%
% of portfolio
0.04%
Previous 0.04%

Shares

12 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

Apr 15, 2024
SELL
$57.6 - $68.62 $1,612 - $1,921
-28 Reduced 1.18%
2,347 $161 Million
Q4 2023

Jan 30, 2024
SELL
$48.64 - $57.81 $9,241 - $10,983
-190 Reduced 7.41%
2,375 $137 Million
Q1 2023

Dec 18, 2023
BUY
$45.09 - $50.03 $33,682 - $37,372
747 Added 41.09%
2,565 $128 Million
Q4 2022

Dec 18, 2023
BUY
$39.56 - $47.22 $71,920 - $85,845
1,818 New
1,818 $84.1 Million
Q1 2022

Dec 18, 2023
SELL
$40.9 - $45.1 $24,826 - $27,375
-607 Reduced 23.66%
1,958 $86.7 Million
Q4 2021

Dec 19, 2023
SELL
$38.07 - $44.87 $6,928 - $8,166
-182 Reduced 32.5%
378 $16.1 Million
Q3 2021

Dec 19, 2023
BUY
$41.23 - $45.88 $9,812 - $10,919
238 Added 73.91%
560 $24.3 Million
Q1 2021

Dec 19, 2023
SELL
$35.27 - $39.67 $11,921 - $13,408
-338 Reduced 51.21%
322 $12.4 Million
Q2 2020

Dec 19, 2023
SELL
$30.19 - $39.11 $57,511 - $74,504
-1,905 Reduced 74.27%
660 $23.2 Million
Q1 2020

Dec 20, 2023
BUY
$25.83 - $45.71 $5,036 - $8,913
195 Added 41.94%
660 $21.5 Million
Q3 2018

Dec 20, 2023
SELL
$32.83 - $38.63 $68,943 - $81,123
-2,100 Reduced 81.87%
465 $17.9 Million
Q4 2016

Dec 21, 2023
SELL
N/A
-2,100
465 $10.1 Million

Others Institutions Holding BSX

# of Institutions
1,323
Shares Held
1.17B
Call Options Held
5.92M
Put Options Held
5.75M
View Full List

About BOSTON SCIENTIFIC CORP

BSX Quotes by TradingView
  • Ticker BSX
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 1,431,609,984
  • Market Cap $109B
  • Description
  • Boston Scientific Corporation develops, manufactures, and markets medical devices for use in various interventional medical specialties worldwide. It operates through three segments: MedSurg, Rhythm and Neuro, and Cardiovascular. The company offers devices to diagnose and treat gastrointestinal and pulmonary conditions; devices to treat various ...
More about BSX
Track This Portfolio

Track West Paces Advisors Inc. Portfolio

Follow West Paces Advisors Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of West Paces Advisors Inc., based on Form 13F filings with the SEC.

News

Stay updated on West Paces Advisors Inc. with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email